Several novel solutions are now available in the Britain for controlling diabetes type 2 . Saxenda, Metformin, and Mounjaro represent different approaches, with copyright and Trulicity being injectable GLP-1 receptor activators primarily aimed at slimming alongside glucose regulation , while Rybe